Phreesia, Inc. (NYSE:PHR – Get Free Report) insider Janet Gunzburg sold 912 shares of the company’s stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $22.85, for a total value of $20,839.20. Following the completion of the transaction, the insider now owns 35,220 shares of the company’s stock, valued at $804,777. The transaction was disclosed in a filing with the SEC, which is available at this link.
Janet Gunzburg also recently made the following trade(s):
- On Wednesday, April 10th, Janet Gunzburg sold 2,768 shares of Phreesia stock. The shares were sold at an average price of $23.10, for a total value of $63,940.80.
- On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $38,657.58.
- On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The stock was sold at an average price of $23.27, for a total value of $65,551.59.
- On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The stock was sold at an average price of $28.00, for a total value of $13,440.00.
- On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The shares were sold at an average price of $25.99, for a total value of $8,524.72.
Phreesia Stock Performance
PHR stock opened at $21.70 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a one year low of $12.05 and a one year high of $34.98. The firm’s 50 day moving average price is $24.28 and its 200-day moving average price is $21.31.
Analyst Ratings Changes
A number of analysts have commented on PHR shares. Truist Financial assumed coverage on Phreesia in a report on Monday, February 26th. They issued a “buy” rating and a $35.00 target price for the company. JMP Securities lifted their target price on Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research report on Thursday, March 21st. Canaccord Genuity Group raised their price target on Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a report on Friday, March 15th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Friday, March 15th. Finally, Robert W. Baird lifted their target price on Phreesia from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, March 18th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.62.
Read Our Latest Stock Report on PHR
Hedge Funds Weigh In On Phreesia
Several institutional investors have recently modified their holdings of the business. International Assets Investment Management LLC grew its stake in shares of Phreesia by 1,987.3% during the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after purchasing an additional 1,411 shares in the last quarter. Captrust Financial Advisors raised its holdings in Phreesia by 154.6% during the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after purchasing an additional 866 shares in the last quarter. Acadian Asset Management LLC purchased a new position in Phreesia during the first quarter worth about $43,000. State of Wyoming increased its holdings in Phreesia by 34.6% in the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after buying an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in Phreesia by 85.4% in the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after buying an additional 1,445 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
See Also
- Five stocks we like better than Phreesia
- Manufacturing Stocks Investing
- MarketBeat Week in Review – 4/15 – 4/19
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Comprehensive Analysis of PayPal Stock
- P/E Ratio Calculation: How to Assess Stocks
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.